Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients

por Romero-Lorca, Alicia, Novillo, Apolonia, Gaibar, María, Bandrés, Fernando, Fernández-Santander, Ana
Publicado 2015

Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer

por Gaibar, Maria, Beltrán, Laura, Romero-Lorca, Alicia, Fernández-Santander, Ana, Novillo, Apolonia
Publicado 2020

Differential expression of PMCA2 mRNA isoforms in a cohort of Spanish patients with breast tumor types

por Romero-Lorca, Alicia, Gaibar, Maria, Armesilla, Angel Luis, Fernandez-Santander, Ana, Novillo, Apolonia
Publicado 2018

FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer

por Gaibar, María, Novillo, Apolonia, Romero-Lorca, Alicia, Malón, Diego, Antón, Beatriz, Moreno, Amalia, Fernández-Santander, Ana
Publicado 2022

HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment

por Novillo, Apolonia, Gaibar, María, Romero-Lorca, Alicia, Malón, Diego, Antón, Beatriz, Moreno, Amalia, Fernández-Santander, Ana
Publicado 2023

Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer

por Gaibar, María, Galán, Miguel, Romero-Lorca, Alicia, Antón, Beatriz, Malón, Diego, Moreno, Amalia, Fernández-Santander, Ana, Novillo, Apolonia
Publicado 2021

Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients

por Fernández-Santander, Ana, Gaibar, María, Novillo, Apolonia, Romero-Lorca, Alicia, Rubio, Margarita, Chicharro, Luis Miguel, Tejerina, Armando, Bandrés, Fernando
Publicado 2013

Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer

por Novillo, Apolonia, Fernández-Santander, Ana, Gaibar, Maria, Galán, Miguel, Romero-Lorca, Alicia, El Abdellaoui-Soussi, Fadoua, Gómez-del Arco, Pablo
Publicado 2021

Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports

por Novillo, Apolonia, Gaibar, María, Romero-Lorca, Alicia, Gilsanz, María Fuencisla, Beltrán, Laura, Galán, Miguel, Antón, Beatriz, Malón, Diego, Moreno, Amalia, Fernández-Santander, Ana
Publicado 2020

miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer

por Romero-Lorca, Alicia, Novillo, Apolonia, Gaibar, María, Gilsanz, María Fuencisla, Galán, Miguel, Beltrán, Laura, Antón, Beatriz, Malón, Diego, Moreno, Amalia, Fernández-Santander, Ana
Publicado 2021